Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crazy Bulk is a prominent health and wellness brand that specializes in the development and retail of dietary supplements marketed as legal alternatives to anabolic steroids. The company's product portfolio is designed to support various bodybuilding objectives, including muscle gain, fat loss, and improved athletic performance, using natural ingredients rather than synthetic hormones. Key products such as D-Bal, Trenorol, and Clenbutrol are formulated to mimic the physiological effects of well-known performance enhancers while maintaining a profile compliant with dietary supplement regulations. Crazy Bulk primarily operates through a direct-to-consumer e-commerce platform, serving a global customer base of fitness enthusiasts and professional athletes. The brand is a subsidiary of Wolfson Brands, a United Kingdom-based company focused on the health, fitness, and beauty sectors. All products are manufactured in GMP-certified facilities to ensure quality and safety standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crazy Bulk.